Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Pei Ying Tong"'
Autor:
Karen Kover, Pei Ying Tong, Dara Watkins, Mark Clements, Lisa Stehno-Bittel, Lesya Novikova, Doug Bittel, Nataliya Kibiryeva, Jacob Stuhlsatz, Yun Yan, Shui Qing Ye, Wayne V Moore
Publikováno v:
PLoS ONE, Vol 8, Iss 3, p e58767 (2013)
Nicotinamide phosphoribosyltransferase (Nampt) is a rate-limiting enzyme in the mammalian NAD+ biosynthesis of a salvage pathway and exists in 2 known forms, intracellular Nampt (iNampt) and a secreted form, extracellular Nampt (eNampt). eNampt can g
Externí odkaz:
https://doaj.org/article/2006e7d80dbe417f9ffda263ff5b29f5
Autor:
Karen Kover, Mark A. Clements, Dara J. Watkins, Yun Yan, James Tasch, Xiaoyu Li, Pei Ying Tong, Melissa Hager, Wayne V. Moore
Publikováno v:
Biochemical and biophysical research communications. 462(1)
Diabetes is characterized by progressive beta cell dysfunction and loss due in part to oxidative stress that occurs from gluco/lipotoxicity. Treatments that directly protect beta cell function and survival in the diabetic milieu are of particular int
Autor:
Dara J. Watkins, Shui Qing Ye, Yun Yan, Karen Kover, Nataliya Kibiryeva, Doug Bittel, Wayne V. Moore, Pei Ying Tong, Lesya Novikova, Jacob Stuhlsatz, Mark A. Clements, Lisa Stehno-Bittel
Publikováno v:
PLoS ONE
PLoS ONE, Vol 8, Iss 3, p e58767 (2013)
PLoS ONE, Vol 8, Iss 3, p e58767 (2013)
Nicotinamide phosphoribosyltransferase (Nampt) is a rate-limiting enzyme in the mammalian NAD+ biosynthesis of a salvage pathway and exists in 2 known forms, intracellular Nampt (iNampt) and a secreted form, extracellular Nampt (eNampt). eNampt can g
Autor:
Christine Eidson, Karen Kover, Ariel M. Bodker, Donna M. Pacicca, Mark A. Clements, Adnan Zaidi, Pei Ying Tong, Audrey Southard, Mary Sheldon, Wayne V. Moore
Publikováno v:
Islets. 3(3)
An important goal in advancing islet transplantation for the treatment for type 1 diabetes, is to discover transplantation sites that promote long-term islet engraftment. Here, we investigate the bone marrow cavity in rats as a potential site for isl
Publikováno v:
Pediatric diabetes. 9(6)
Background: Anti-CD25 and mycophenolate mofetil (MMF) treatment of patients with new-onset diabetes is currently being tested as one of the trials in TrialNet. We tested the effectiveness of MMF and anti-CD25 in preventing autoimmune diabetes in the
Publikováno v:
Pediatric Diabetes; Dec2008, Vol. 9 Issue 6, p596-601, 6p, 1 Chart, 2 Graphs
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.